Literature DB >> 18972530

Quantitative protein microarrays for time-resolved measurements of protein phosphorylation.

Ulrike Korf1, Sophia Derdak, Achim Tresch, Frauke Henjes, Sabrina Schumacher, Christian Schmidt, Bettina Hahn, Wolf D Lehmann, Annemarie Poustka, Tim Beissbarth, Ursula Klingmüller.   

Abstract

The quantitative analysis of signaling networks requires highly sensitive methods for the time-resolved determination of protein phosphorylation. For this reason, we developed a quantitative protein microarray that monitors the activation of multiple signaling pathways in parallel, and at high temporal resolution. A label-free sandwich approach was combined with near infrared detection, thus permitting the accurate quantification of low-level phosphoproteins in limited biological samples corresponding to less than 50,000 cells, and with a very low standard deviation of approximately 5%. The identification of suitable antibody pairs was facilitated by determining their accuracy and dynamic range using our customized software package Quantpro. Thus, we are providing an important tool to generate quantitative data for systems biology approaches, and to drive innovative diagnostic applications.

Mesh:

Substances:

Year:  2008        PMID: 18972530     DOI: 10.1002/pmic.200800112

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  14 in total

Review 1.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

2.  Variable slope normalization of reverse phase protein arrays.

Authors:  E Shannon Neeley; Steven M Kornblau; Kevin R Coombes; Keith A Baggerly
Journal:  Bioinformatics       Date:  2009-03-31       Impact factor: 6.937

Review 3.  STATus and Context within the Mammalian Nervous System.

Authors:  Prithi Rajan
Journal:  Mol Med       Date:  2011-05-20       Impact factor: 6.354

4.  The effect of branched chain amino acids on skeletal muscle mitochondrial function in young and elderly adults.

Authors:  Laura L Tatpati; Brian A Irving; Andrea Tom; Maureen L Bigelow; Katherine Klaus; Kevin R Short; K Sreekumaran Nair
Journal:  J Clin Endocrinol Metab       Date:  2009-12-18       Impact factor: 5.958

5.  Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification.

Authors:  Jan C Brase; Heiko Mannsperger; Holger Fröhlich; Stephan Gade; Christian Schmidt; Stefan Wiemann; Tim Beissbarth; Thorsten Schlomm; Holger Sültmann; Ulrike Korf
Journal:  Proteome Sci       Date:  2010-06-22       Impact factor: 2.480

6.  Development of high-yield autofluorescent protein microarrays using hybrid cell-free expression with combined Escherichia coli S30 and wheat germ extracts.

Authors:  Xristo Zárate; David C Henderson; Keenan C Phillips; April D Lake; David W Galbraith
Journal:  Proteome Sci       Date:  2010-06-15       Impact factor: 2.480

Review 7.  Yeast proteomics and protein microarrays.

Authors:  Rui Chen; Michael Snyder
Journal:  J Proteomics       Date:  2010-08-20       Impact factor: 4.044

Review 8.  Emerging affinity-based techniques in proteomics.

Authors:  Shengnan Xie; Colby Moya; Betul Bilgin; Arul Jayaraman; S Patrick Walton
Journal:  Expert Rev Proteomics       Date:  2009-10       Impact factor: 3.940

9.  RNAi-based validation of antibodies for reverse phase protein arrays.

Authors:  Heiko A Mannsperger; Stefan Uhlmann; Christian Schmidt; Stefan Wiemann; Ozgür Sahin; Ulrike Korf
Journal:  Proteome Sci       Date:  2010-12-23       Impact factor: 2.480

10.  Heterogeneous kinetics of AKT signaling in individual cells are accounted for by variable protein concentration.

Authors:  René Meyer; Lorenza A D'Alessandro; Sandip Kar; Bernhard Kramer; Bin She; Daniel Kaschek; Bettina Hahn; David Wrangborg; Johan Karlsson; Mats Kvarnström; Mats Jirstrand; Wolf-Dieter Lehmann; Jens Timmer; Thomas Höfer; Ursula Klingmüller
Journal:  Front Physiol       Date:  2012-11-28       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.